Abstract
The tremendous amplification inherent in hematopoietic development in vivo has long tantalized clinician scientists with the notion that this physiology could be harnessed for clinical application. In these scenarios, ex vivo culture of hematopoietic cells could be employed for the generation of myeloid and lymphoid cells of various maturities and degrees of modifications, ranging from amplified stem cells to transfusion doses of mature red blood cells and platelets. Over the past decade, advances in our understanding of hematopoietic physiology have allowed investigators to begin to address these issues, and clinical trials are beginning to explore these possibilities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Haylock, D.N., To, L.B., Dowse, T.L., Juttner, C.A., Simmons P.J.. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992; 80: 1405–1412.
Srour, E.G., Brandt, J.E., Briddell, R.A., Grigsby, S., Leemhuis, T., Hoffman, R. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 1993; 81: 661–669.
Coutinho, L.H., Will, A., Radford, J., et al. Effects of recombinant human granulocyte colony-stimulating factor(CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Blood 1990; 75: 21182129.
Brugger, W., Mocklin, W., Heimfeld, S., Berenson, R.J., Mertelsmann, KanzL. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin 1ß(IL-lß), I1-6, I1-3, interferon-γ and erythropoietin. Blood 1993; 81: 2579–2584.
Henschler, R., Brugger, W., Luft, T., Frey, T., Mertelsmann, R., Kanz, L. Maintenance of transplantation potential in ex vivo expanded CD34+-selected human peripheral blood progenitor cells. Blood 1994; 84: 2898–2903.
Caldwell, J., Locey, B., Palsson, B.O., Emerson, S.G.: The influence of culture perfusion conditions on normal human bone marrow stromal cell metabolism. J Cell Physiol 1991; 147: 344–353.
Caldwell, J., Locey, B., Clarke, M.F., Emerson, S.G., Palsson, B.O.: The influence of culture conditions on genetically engineered NIH-3T3 cells. Biotech Prog 1991;7: 1–8.
Guba, S.C., Sartor, C.I., Gottschalk, L.R., Ye-Hu, J., Xiao, L.C., Mulligan, T., Emerson, S.G. Bone marrow stromal cells secrete IL-6 and GM-CSF in the absence of inflammatory stimuli: Demonstration by serum-free bioassay, ELISA, and reverse transcriptase polymerase chain reaction. Blood 1992; 80: 1190–1198.
Schwartz, R., Palsson, B.O., Emerson, S.G.: Rapid medium and serum exchange increases the longevity and productivity of human bone marrow cultures. Proc Nat Acad Sci USA 1991; 88: 6760–6764.
Schwartz, R., Emerson, S.G., Clarke, M.F., Palsson, B.O.: In vitro myelopoiesis stimulated by rapid medium exchange and supplementation with hematopoietic growth factors. Blood 1991; 78: 3155–3161.
Roller, M.R., Emerson, S.G. Palsson, B.O. Large-Scale Expansion of Human Hematopoietic Stem and Progenitor Cells from Bone Marrow Mononuclear Cells in Continuous Perfusion Culture. Blood 1993; 82: 378–384.
Roller, M.R., Palsson, M.A., Manchel, I., et al. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood 1995; 86(5): 1784–1793.
Zandstra, P.W., Eaves, C.J., Cameron, C, and Piret, J.M. Cytokine depletion in long-term stirred suspension cultures of normal human marrow. J Hematoth 1995; 4: 235.
Champlin, R., Mehra, R., Gajewski, J., Rhouri, I., Geisler, D., Davis, M., Oba, R., Thomas, M., Armstrong, R.D., Douville, J., Weber, S., Silver, S., Muller, T., Deisseroth, A. Ex Vivo expanded progenitor cell transplantation in patients with breast cancer. Blood 1995; 86: Suppl 1166a.
Holyoake, T.L., Alcorn, M.J., Richmond, L., Pearson, C, Farrell, E., Kyle, B., Dunlop, D.J., Fitzsimons, E., Steward, W.P., Pragnell, I.B., Franklin, I.M. Phase I study to evaluate the safety of re-infusing CD34 cells expanded ex vivo as part or all of a PBPC transplant procedure. Blood 1995; 86: Suppl 1161a.
Broxmeyer, H.E., Douglas G.W., Hangoc G., Cooper, S., Bard, J., English, D., Amy, M., Thomas, L., Boyse, E.A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U.S.A. 1989; 86: 3828–3923.
Broxmeyer, H.E., Hangoc, G., Cooper, S., Ribeiro, R.C., Graves, V., Yoder, N.M., Wagner, J., Vadhan-Raj, S., Benninger, L., Rubinstein, P. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992;89: 4109–4113.
Fleischman, R.A., Mintz, B., Development of adult bone marrow stem cells in H-2-compatible and-incompatible mouse fetuses. J Exp Med 1984; 159: 731–745.
Carow, C.E., Hangoc, G., Broxmeyer, H.E. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary (CFU-GEMM): An effect enhanced by cord blood plasma. Blood 1993; 81: 942–949.
Mayani, H., Lansdorp, P.M. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994; 83: 2410–2417.
Gluckman, E., Devergie, A., Bourdeau-Esperou, H., Theirry, D., Traineau, R., Auerbach, A., Broxmeyer, H.E. Transplantation of umbilical cord blood in Fanconi’s anemia. Nouv Rev Fr Hematol 1990; 32: 423–435.
Wagner, J.E., Kernan, N.A., Steinbuch, M., Broxmeyer, H.E., Gluckman, E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214–219.
Moore, M.A.S., Hoskins, I. Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells 1994; 20: 468–481.
Mayani, H, Little, M-T., Dragowska, W., Thornbury, G., Lansdorp, P.M. Differential effects of the hematopoietic inhibitors MIP-1α, TGF-ß, and TNF-α on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Exp Hematol 1995; 23: 422–427.
Spooncer, E., Dexter, T.M. Transplantation of long term cultured bone marrow cells. Transplantation 1984; 35: 624–627.
Chang, J., Morgenstern, G., Deakin, D., Testa, N.G., Coutinho, L., Scharffe, J.H., Harrison, C, Dexter, T.H. Reconstitution of haemopoietic system with autologous marrow taken during relapse of acute myeloblasts leukaemia and grown in long-term culture. Lancet 1986; 294–295.
Barnett, M.J., Eaves, C.J., Phillips, G.L., Kalousek D.K., Klingemann, H.G., Lansdorp, P.M., Reece, D.E., Shepherd, J.D., Shaw, G.J., Eaves, A.C. Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplantation 1989; 4: 345–351.
Silver, S.M., Adams, P.T., Hutchinson, R.J., Douville, J.W., Paul, L.A., Clarke, M.F., Palsson, B.O., Emerson, S.G. Phase I evaluation of ex vivo expanded hematopoietic cells produced by perfusion culture in autologous bone marrow transplantation(ABMT). Blood Suppl 1993; 1 82:297a.
Bender, J.G., Zimmerman, T., Lee, W.J., Loudovaris, M.F., Qiao, X., Schilling, M.L., Smith, S.L., Unverzagt, K.L., Van Epps, D.E., Blake, M., Williams, D.E., Williams, S. Large scale selection and expansion of CD34+ cells in PIXY321: Phase I/II Clinical Studies. J Hematoth 1995; 4: 237.
Brugger, W., Heimfeld, S., Berenson, R.J., Mertelsmann, R., Kanz, L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995; 333: 283–287.
Eipers, P.G., Krause, J.C., Palsson, B.O., Emerson, S.G., Todd, R.F., Clarke, M.F. Retroviral infection of primitive hematopoietic cells in continuous perfusion culture. Blood 1995; 86: 3754–3762;.
Pacibello, W., Sanavio, F., Garetto, L., Severino, A., Bergandi, D., Farrario, J., Faglioli, F., Berger, M, Aglietta, M. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644–2653;.
Jaroscak, J., P.L. Martin, B. Waters-Pick, R.D. Armstrong, T. Driscoll, R.P. Howrey, S. Castellinol J. Douville, S. kBukrhop, K. Goltry, P. Rubinstein, A. Smith, J. Kurtzberg, J. A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex vivo expanded cells. Blood 1998; 92 Supl: 523a.
Mauch P. Botnick LE. Hannon EC. Obbagy J. Hellman S. Decline in bone marrow proliferative capacity as a function of age. Blood. 1982; 60: 245–252.
Mauch P. Hellman S. Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood. 1989; 74(2): 872–875.
Iscove NN. Nawa K. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion. Current Biology 1997; 7(10): 805–808.
Lansdorp PM. Developmental changes in the function of hematopoietic stem cells. Experimental Hematology 1995; 23(3): 187–191.
Vaziri H. Dragowska W. Allsopp RC. Thomas TE. Harley CB. Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proceedings of the National Academy of Sciences of the United States of America 1994; 91(21): 9857–9860.
Akiyama M. Hoshi Y. Sakurai S. Yamada H. Yamada O. Mizoguchi H. Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplantation 1998; 21(2): 167–171.
Wynn RF. Cross MA. Hatton C. Will AM. Lashford LS. Dexter TM. Testa NG. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998; 351(9097): 178–181.
Notaro R. Cimmino A. Tabarini D. Rotoli B. Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells.Proc Nat Acad Sci USA 1997; 94: 13782–13785.
Bodine, D.M., Seidel, N.E., Zsebo, K.M, Orlic, D. In vivo administration of stem cell factor mice increases the absolute number of pluripotent stem cells. Blood 1993; 82: 445–455.
Yonemura, Y., Ku, H., Lyman, S.D., Ogawa, M. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between flt3/flk2 ligand and kitligand. Blood 1997; 89: 1915–1921.
Nandurkar, H.H., Robb, L., Tarlinton, D., Barnett, L., Kontgen, F., Beglet C.G. Adult mice with targeted mutation of the interluekin-11 receptor display normal hematopoiesis. Blood 1997;90: 2148–2159.
Miller, C.L., Eaves, C.J. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci USA 1997;94: 13648–13651.
Macharehtschian K., Hardin, J.D., Moore, K.A., Boast, S., Goff, S.F., Lemischka, I, R. Targeted disruptoin of the fltk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995; 3: 147–156.
Pecora, A.L., Stiff, P., Jennis, A., Goldberg, S., Rosenbluth, R., Price, P., Douvile, J., Armonstrong, R., Smith, A., Preti, R. Rapid and durable engraftment in two patients with high risk CML using unexpanded and expanded umbilical cord blood stem cells. 1999 ASBMT Meeting, Keystone, CO, Abstr. #62, pl8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Emerson, S.G., Conrad., P.D. (1999). Clinical Application of Hematopoietic Stem Cell Culture and Expansion. In: Burt, R.K., Brush, M.M. (eds) Advances in Allogeneic Hematopoietic Stem Cell Transplantation. Cancer Treatment and Research, vol 101. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4987-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4987-1_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7264-6
Online ISBN: 978-1-4615-4987-1
eBook Packages: Springer Book Archive